Overview

This is a Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Espisode Associated With Bipolar I Disorder (Bioplar I Depression).

Status:
Not yet recruiting
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
This is a clinical trial to determine the long-term safety and tolerability of an investigational drug in people with Major Depressive Espisode Associated with Bipolar I Disorder (Bioplar I Depression). Participants in the study will receive the drug being studied. This study is accepting male and female participants between 18 and 65 years old who have completed Study SEP380-301. This study will be conducted in approximately 90 study centers worldwide. The treatment duration for this study is one (1) year.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion